Latest News for: lung cancer

Edit

AdventHealth Gordon Earns ACR Lung Cancer Screening Center Designation

Walker & Catoosa County News 17 Jun 2026
The ACR Lung Cancer Screening Center designation is awarded to facilities that have achieved ACR accreditation in computed tomography imaging and demonstrate that their lung cancer screening program ...
Edit

Small Cell Lung Cancer Pipeline Shows Strong Momentum as 100+ Pharma Companies in the Race ...

GetNews 17 Jun 2026
Vernalis Inactive Products Small Cell Lung Cancer Key Companies Small Cell Lung Cancer Key Products Small Cell Lung Cancer- Unmet Needs Small Cell Lung Cancer- Market Drivers and Barriers Small Cell ...
Edit

Attachment 39 - IASLC World Conference on Lung Cancer Sept. 2025 (The eRulemaking Program)

Public Technologies 16 Jun 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132500223) .
Edit

Cizzle Bio Announces Laboratory Validation of CIZ1B Biomarker Blood Test for Early Lung Cancer at OmniHealth Diagnostics

PR Newswire 16 Jun 2026
DALLAS, June 16, 2026 /PRNewswire/ -- Cizzle Bio, Inc., a Texas-based biotechnology company advancing biomarker blood tests for early detection of lung and gastric cancers, today announced the ...
Edit

The Silent Shift: How Tech and Biology are Redefining Lung Cancer (Personalis Inc)

Public Technologies 15 Jun 2026
). The text version of this document is not available ... Disclaimer. Personalis Inc.
Edit

IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Combination Study in MTAP-Deleted Pancreatic and Lung Cancers (IDEAYA Biosciences Inc)

Public Technologies 15 Jun 2026
IDE892 monotherapy expansion is anticipated in Q3 2026 MTAP-deletion is estimated to occur in up to 40% of pancreatic cancer and ~15% of non-small cell lung cancer (NSCLC) ... non-small cell lung cancer.
Edit

IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Combination Study in MTAP-Deleted Pancreatic and Lung Cancers

PR Newswire 15 Jun 2026
IDE892 monotherapy expansion is anticipated in Q3 2026 MTAP-deletion is estimated to occur in up to 40% of pancreatic cancer and ~15% of non-small cell lung cancer (NSCLC) ... cell lung cancer.
Edit

Can lung cancer be prevented using a drug?

The Hindu 13 Jun 2026
... help make screening programmes for lung cancer more efficient.
Edit

Vaping after quitting smoking is linked to lung cancer

New Scientist 12 Jun 2026
A study of 4.5 million people suggests that ex-smokers who take up vaping are more at risk of dying from lung cancer than people who quit without the use of e-cigarettes ... .
Edit

VA Research Wrap Up: New findings on lung cancer, AI and bone regeneration (US Department of Veterans Affairs)

Public Technologies 12 Jun 2026
... findings new findings on lung cancer survival rates, using AI for health apps, and how temperature affects bone regeneration.
Edit

Capito Applauds Passage of Women’s Lung Cancer Prevention Bill (Shelley Moore Capito)

Public Technologies 12 Jun 2026
Departments of Defense (DoD) and Veterans' Affairs (VA) to conduct a comprehensive review across departments of ongoing research that could help us better understand and respond to the increasing number of women being diagnosed with lung cancer.
Edit

Rural clinics in Minnesota aim to boost lung cancer screening rates

SC Times 12 Jun 2026
Barry Manilow says he's physically ready to return to the stage after lung cancer surgery, but the 82-year-old singer told "Good Morning America" he's still unsure whether his voice will come back.
Edit

Jazz Pharmaceuticals Provides Update on Zepzelca® (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung Cancer

PR Newswire 12 Jun 2026
About Small Cell Lung Cancer In the U.S., approximately 13 percent of lung cancers are small cell.1 Approximately 30,000 new cases of small cell lung cancer (SCLC) are reported in the U.S ... What Is Lung ...
×